Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus in metastatic recurrent/unresectable renal cell carcinoma
NCT01206764Phase 4Completed
- Sponsor
- Novartis
- Start
- Nov 2009
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 4 trial of everolimus in renal cell carcinoma (RCC), sponsored by Novartis. Started Nov 2009; status: completed.
02
Drugs
everolimus
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT01206764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01206764.